ACHROMATOPSIA
Clinical trials for ACHROMATOPSIA explained in plain language.
Never miss a new study
Get alerted when new ACHROMATOPSIA trials appear
Sign up with your email to follow new studies for ACHROMATOPSIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a liver drug help people see color? tiny trial launched
Symptom relief TerminatedThis early-phase trial tests whether an FDA-approved drug called glycerol phenylbutyrate (PBA) can improve vision in people with a rare form of color blindness caused by mutations in the ATF6 gene. Only 2 participants are enrolled, and they will take PBA three times daily while t…
Matched conditions: ACHROMATOPSIA
Phase: EARLY_PHASE1 • Sponsor: Columbia University • Aim: Symptom relief
Last updated Jun 26, 2026 15:34 UTC
-
New registry tracks vision loss in rare eye diseases
Knowledge-focused OngoingThis study collects information from about 889 people with inherited retinal diseases (IRDs) to understand how vision changes over time. Participants have their eyesight and visual field tested regularly. The goal is to learn more about the natural course of these rare eye condit…
Matched conditions: ACHROMATOPSIA
Sponsor: Janssen Research & Development, LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC